p53 attenuates AKT signaling by modulating membrane phospholipid composition
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
// Natalia Rueda-Rincon 1 , Katarzyna Bloch 1 , Rita Derua 2 , Rajesh Vyas 3, 4 , Amy Harms 5, 6 , Thomas Hankemeier 5, 6 , Niamat Ali Khan 1 , Jonas Dehairs 1 , Muralidhararao Bagadi 1 , Maria Mercedes Binda 7 , Etienne Waelkens 2 , Jean-Christophe Marine 3, 4 , Johannes V. Swinnen 1 1 KU Leuven - University of Leuven, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, Leuven, Belgium 2 KU Leuven - University of Leuven, Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, Leuven, Belgium 3 KU Leuven - University of Leuven, Center for the Biology of Disease, Laboratory for Molecular Cancer Biology, VIB, Leuven, Belgium 4 KU Leuven - University of Leuven, Department of Human Genetics, Laboratory for Molecular Cancer Biology, VIB, Leuven, Belgium 5 Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands 6 Netherlands Metabolomics Centre, Leiden, The Netherlands 7 Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Gynécologie, Bruxelles, Belgium Correspondence to: Johannes V. Swinnen, e-mail: johan.swinnen@med.kuleuven.be Keywords: p53, SCD, SREBP, phospholipids, cancer Received: February 03, 2015 Accepted: May 21, 2015 Published: June 03, 2015 ABSTRACT The p53 tumor suppressor is the central component of a complex network of signaling pathways that protect organisms against the propagation of cells carrying oncogenic mutations. Here we report a previously unrecognized role of p53 in membrane phospholipids composition. By repressing the expression of stearoyl-CoA desaturase 1, SCD, the enzyme that converts saturated to mono-unsaturated fatty acids, p53 causes a shift in the content of phospholipids with mono-unsaturated acyl chains towards more saturated phospholipid species, particularly of the phosphatidylinositol headgroup class. This shift affects levels of phosphatidylinositol phosphates, attenuates the oncogenic AKT pathway, and contributes to the p53-mediated control of cell survival. These findings expand the p53 network to phospholipid metabolism and uncover a new molecular pathway connecting p53 to AKT signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 2×
“This network encompasses direct effectors of these processes, including the cyclin-dependent kinase inhibitor 1A (p21), the p53 upregulated modulator of apoptosis (PUMA) and the BCL2-associated X protein (BAX), but also involves many indirect effects and cross-talks with (proto-)oncogenes and other tumor suppressors […”
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967 · cited 1×
“It is lost or mutated in more than 50% of all human cancers and there is increasing evidence that, although wild-type, p53 function is compromised in the remaining cancers [3].”
iRegulon: From a Gene List to a Gene Regulatory Network Using Large Motif and Track Collections
Janky, R., Verfaillie, A., Imrichová, H., Van de Sande, B., Standaert, L., Christiaens, V., Hulselmans, G., Herten, K., Naval Sanchez, M., Potier, D., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003731 · Cited by 900 · cited 1×
“The lack of p53binding sites in the SREBP1 promoter region in existing ChIP-seq data [40, 41], the presence of E2F binding sites, and the lack of p53-mediated changes in mono-unsaturation in p21 knockout cells give support to this concept.”
Self-citationHooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011338 · Cited by 772
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
p53 and its mutants in tumor cell migration and invasion
Muller, P. A. J., Vousden, K. H., & Norman, J. C. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009059 · Cited by 463
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278
Oncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155
Research works printed but not linked: 40
- Crawford, 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, 261, 10.1038/278261a0 · DOI · Paper page
- Levine, 1979, Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9 · DOI · Paper page
- Levine, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
- Vousden, 2013, Metabolic regulation by p53 family members, Cell Metab, 18, 617, 10.1016/j.cmet.2013.06.019 · DOI · Paper page
- Vousden, 2010, p53 regulation of metabolic pathways, Cold Spring Harb Perspect Biol, 2, a001040
- Feng, 2013, The regulation of cellular metabolism by tumor suppressor p53, Cell & bioscience, 3, 9, 10.1186/2045-3701-3-9 · DOI · Paper page
- Lindblom, 2007, Domain formation in model membranes studied by pulsed-field gradient-NMR: the role of lipid polyunsaturation, Biophys J, 93, 3182, 10.1529/biophysj.107.111534 · DOI · Paper page
- Feigenson, 2008, Membrane lipids: where they are and how they behave, Nature reviews Molecular cell biology, 9, 112, 10.1038/nrm2330 · DOI · Paper page
- Damjanovich, 2003, Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model, Proc Natl Acad Sci U S A, 100, 8053, 10.1073/pnas.1332550100 · DOI · Paper page
- Verhoeven, 2006, Increased lipogenesis in cancer cells: new players, novel targets, Current opinion in clinical nutrition and metabolic care, 9, 358, 10.1097/01.mco.0000232894.28674.30 · DOI · Paper page
- Ferber, 2013, Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth, Cancer & metabolism, 1, 3, 10.1186/2049-3002-1-3 · DOI · Paper page
- Chung, 2012, Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells, Molecular cancer research : MCR, 10, 133, 10.1158/1541-7786.MCR-11-0206 · DOI · Paper page
- Munck, 2010, De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation, Cancer Res, 70, 8117, 10.1158/0008-5472.CAN-09-3871 · DOI · Paper page
- York, 2013, An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity, Cancer Res, 73, 2850, 10.1158/0008-5472.CAN-13-0382-T · DOI · Paper page
- Shyy, 2004, Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis, Circulation research, 95, 471, 10.1161/01.RES.0000139956.42923.4A · DOI · Paper page
- Schimmer, 2011, Inhibition of SREBP1 sensitizes cells to death ligands, Oncotarget, 2, 186, 10.18632/oncotarget.239 · DOI
- Agarwal, 2014, Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1, Oncotarget, 5, 10017, 10.18632/oncotarget.2488 · DOI
- Liu, 2004, activation of the p53 pathway by small-molecule antagonists of MDM2, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
- Perry, 2003, mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation, Mol Cell Biol, 23, 462, 10.1128/MCB.23.2.462-473.2003 · DOI · Paper page
- Ntambi, 2009, Biochemical and physiological function of stearoyl-CoA desaturase, Am J Physiol Endocrinol Metab, 297, E28, 10.1152/ajpendo.90897.2008 · DOI · Paper page
- Nakagawa, 2003, p53 Activation in adipocytes of obese mice, J Biol Chem, 278, 25395, 10.1074/jbc.M302364200 · DOI · Paper page
- Espinosa, 2014, Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms, eLife, 3, e02200, 10.7554/eLife.02200 · DOI · Paper page
- Snyder, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
- Igal, 2008, Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis, International journal of oncology, 33, 839
- McGraw, 2009, The Akt kinases: isoform specificity in metabolism and cancer, Cell Cycle, 8, 2502, 10.4161/cc.8.16.9335 · DOI · Paper page
- Epand, 2012, Phosphatidylinositol-4-phosphate 5-kinase isoforms exhibit acyl chain selectivity for both substrate and lipid activator, J Biol Chem, 287, 35953, 10.1074/jbc.M112.370155 · DOI · Paper page
- Rassidakis, 2007, Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma, Clin Cancer Res, 13, 3380, 10.1158/1078-0432.CCR-06-2581 · DOI · Paper page
- Hosoi, 2009, Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells, Clin Cancer Res, 15, 4077, 10.1158/1078-0432.CCR-08-2955 · DOI · Paper page
- Horton, 1998, Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver, J Biol Chem, 273, 35299, 10.1074/jbc.273.52.35299 · DOI · Paper page
- Edwards, 1999, Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2, J Biol Chem, 274, 20603, 10.1074/jbc.274.29.20603 · DOI · Paper page
- Aaronson, 2014, p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes, Oncogene, 33, 3959, 10.1038/onc.2013.378 · DOI · Paper page
- Avances, 2010, Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice, Molecular cancer therapeutics, 9, 1740, 10.1158/1535-7163.MCT-09-1064 · DOI · Paper page
- Copland, 2013, Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma, Clin Cancer Res, 19, 2368, 10.1158/1078-0432.CCR-12-3249 · DOI · Paper page
- Igal, 2011, Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis, Cancers, 3, 2462, 10.3390/cancers3022462 · DOI
- Rialland, 2010, Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells, PLoS One, 5, e14363, 10.1371/journal.pone.0014363 · DOI
- Testa, 2005, Perturbations of the AKT signaling pathway in human cancer, Oncogene, 24, 7455, 10.1038/sj.onc.1209085 · DOI · Paper page
- Oren, 2002, Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis, Oncogene, 21, 1299, 10.1038/sj.onc.1205181 · DOI · Paper page
- Mak, 2001, Regulation of PTEN transcription by p53, Mol Cell, 8, 317, 10.1016/S1097-2765(01)00323-9 · DOI · Paper page
- Qing, 2012, FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth, Cancer Res, 72, 5843, 10.1158/0008-5472.CAN-12-1329 · DOI
- Vreeken, 2014, Enhanced lipid isomer separation in human plasma using reversed-phase UPLC with ion-mobility/high-resolution MS detection, J Lipid Res, 55, 1772, 10.1194/jlr.D047795 · DOI
Cited by
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Self-citationLacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
The complexity of p53-mediated metabolic regulation in tumor suppression
Liu, Y., & Gu, W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 261
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Talebi, A., Dehairs, J., Rambow, F., Rogiers, A., Nittner, D., Derua, R., Vanderhoydonc, F., Duarte, J. A. G., Bosisio, F., Van den Eynde, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04664-0 · Cited by 155
Self-citationPhosphatidylinositol synthesis at the endoplasmic reticulum
Blunsom, N. J., & Cockcroft, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.05.015 · Cited by 116
How is the acyl chain composition of phosphoinositides created and does it matter?
Barneda, D., Cosulich, S., Stephens, L., & Hawkins, P. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190205 · Cited by 65
Thibault, B., Ramos-Delgado, F., & Guillermet-Guibert, J. (2023) · Cancers · doi:10.3390/cancers15030784 · Cited by 40
Metadata
- Authors
- Rueda-Rincon, N., Bloch, K., Derua, R., Vyas, R., Harms, A., Hankemeier, T., Khan, N. A., Dehairs, J., Bagadi, M., Binda, M. M., Waelkens, E., Marine, J.-C., & Swinnen, J. V.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-06-03
- Volume
- 6
- Issue
- 25
- Pages
- 21240-21254
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1552458787
- Cited by
- 46
- References
- 12
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.